NPM1 and acute myeloid leukemia: This frequency was in agreement with many previous studies in Egypt and worldwide as reported by (Falini et al., 2008; Farawela et al., 2014; Kassem et al., 2019) where the frequency of NPM1 mutation ranged between 30–52.9% among their AML patients.